Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

A Disease Registry of Patients With Mantle Cell Lymphoma

ClinicalTrials.gov ID: NCT03816683

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03816683. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 3:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life: A Prospective Disease Registry of Patients With Mantle Cell Lymphoma Treated With Novel Agents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to create a patient registry in order to assess treatment patterns, physician reported clinical outcomes and patient-reported health-related quality of life among patients diagnosed with Mantle Cell Lymphoma (MCL) who newly initiated a novel therapy in the past 6 months and whose treatment is ongoing at the time of enrollment.

Study identification

NCT ID
NCT03816683
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
AstraZeneca
Industry
Enrollment
227 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2019 (Actual)
Primary completion
Mar 18, 2024 (Actual)
Completion
Mar 18, 2024 (Actual)
Last update posted
Nov 14, 2025

2019 – 2024

United States locations

U.S. sites
32
U.S. states
19
U.S. cities
29
Facility City State ZIP Site status
Research Site Montgomery Alabama 36101 —
Research Site Clovis California 93611 —
Research Site Boulder Colorado 80303-1385 —
Research Site Jacksonville Florida 32256 —
Research Site Pensacola Florida 32503 —
Research Site Tampa Florida 33612-9497 —
Research Site Atlanta Georgia 30322 —
Research Site Augusta Georgia 30912 —
Research Site Chicago Illinois 60612 —
Research Site Iowa City Iowa 52242 —
Research Site Ann Arbor Michigan 48109 —
Research Site Duluth Minnesota 55805 —
Research Site Saint Louis Park Minnesota 55416 —
Research Site Saint Paul Minnesota 55102 —
Research Site Lincoln Nebraska 68510 —
Research Site Berkeley Heights New Jersey 07922 —
Research Site Hackensack New Jersey 07601 —
Research Site East Syracuse New York 13057 —
Research Site New York New York 10022 —
Research Site Eugene Oregon 97401-8122 —
Research Site Danville Pennsylvania 17822 —
Research Site Philadelphia Pennsylvania 19104 —
Research Site Philadelphia Pennsylvania 19111 —
Research Site Nashville Tennessee 37232 —
Research Site Dallas Texas 75231 —
Research Site Dallas Texas 75390 —
Research Site Houston Texas 77030 —
Research Site San Antonio Texas 78229 —
Research Site Seattle Washington 98122 —
Research Site Seattle Washington 98195-9472 —
Research Site Morgantown West Virginia 26506 —
Research Site Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03816683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2025 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.